Calavo (CVGW) Lacks Quality Metrics, Analysts Recommend Avoiding Post-Q3

Calavo Growers (CVGW) faces skepticism from analysts following its Q3 earnings, with a recommendation to avoid the stock due to weak fundamentals. The shares, trading at $25.38 as of February 3, 2026, have declined 4.2% over six months—underperforming the S&P 500’s 9.6% gain. Revenue has contracted at an 18.3% annual rate over the past three years, reflecting inconsistent demand. With $648.4 million in trailing 12-month revenue, the small-cap consumer staples firm struggles with poor unit economics, averaging just a 10% gross margin over two years—indicating limited pricing power and high cost of goods sold. Its forward P/E of 16.4x suggests elevated expectations not justified by underlying performance. Analysts favor higher-quality alternatives, citing superior growth and margins elsewhere.